There were 451 press releases posted in the last 24 hours and 401,715 in the last 365 days.
Please use this form to send email to PR contact of this press release:
Avotres Announces Achieving Primary Endpoint of its Phase 1/2 Clinical Trial of AVT001 in Patients with Type 1 Diabetes
TO:
Emmie Fan
Avotres Inc.
+1 973-487-6972